Twitter | Search | |
Asterias Bio
For more information, please visit
81
Tweets
0
Following
167
Followers
Tweets
Asterias Bio Nov 1
Reply Retweet Like
Asterias Bio Oct 10
Reply Retweet Like
Asterias Bio Sep 6
Reply Retweet Like
Asterias Bio Aug 3
Asterias to report Q2 2018 results on August 9:
Reply Retweet Like
Asterias Bio Jul 25
AST-OPC1 to be investigated as treatment for stroke. Read more here:
Reply Retweet Like
Asterias Bio Jul 23
Asterias releases 6-month data readout on AST-OPC1 Phase 1/2a clinical trial in severe spinal cord injury:
Reply Retweet Like
Asterias Bio Jul 16
SF Chronicle story profiling patients who are seeking out stem cell treatments. Story includes Mary Ambery who is participating in the AST-OPC1 clinical trial:
Reply Retweet Like
Asterias Bio Jul 12
Asterias Announces Positive Outcome from Safety Review Committee for AST-VAC2; Recommends Continuation of Clinical Trial in Non-Small Cell Lung Cancer (NSCLC):
Reply Retweet Like
Asterias Bio Jun 14
First patient dosed in VAC2 study!
Reply Retweet Like
Asterias Bio May 11
Asterias reports Q1 results and recent business progress:
Reply Retweet Like
Asterias Bio May 9
AST-VAC2 Update:
Reply Retweet Like
Asterias Bio 1 Mar 18
Asterias releases latest data on AST-OPC1 clinical trial:
Reply Retweet Like
Asterias Bio 23 Feb 18
Asterias adds 46 new patents to its global IP protection:
Reply Retweet Like
Asterias Bio 20 Dec 17
Enrollment completed for SciStar Study!
Reply Retweet Like
Asterias Bio 16 Nov 17
What Once Was Lost |
Reply Retweet Like
Asterias Bio 16 Nov 17
Asterias releases Q3 2017 results:
Reply Retweet Like
Asterias Bio 18 Oct 17
Asterias announces $10.4 million registered direct offering:
Reply Retweet Like
Asterias Bio 16 Oct 17
Press release from Rush Medical, one of the clinical sites for AST-OPC1:
Reply Retweet Like
Asterias Bio 4 Oct 17
Spinal Patients Continue Remarkable Recovery After Stem Cell Injections, Company Says
Reply Retweet Like
Asterias Bio retweeted
ARM 2 Oct 17
Asterias's AST-OPC1 injury program receives FDA's designation -
Reply Retweet Like